Document Detail


CATHETER ABLATION OF LONE ATRIAL FIBRILLATION.
MedLine Citation:
PMID:  25175086     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Atrial fibrillation is the most common sustained arrhythmia in clinical practice, associated with increased mortality, risk of stroke and heart failure, as well as the reduction of the quality of life. Atrial fibrillation may be encountered in young otherwise healthy individuals, due to the isolated electrophysiological disorder limited mostly to the pulmonary veins and posterior left atrial wall, or associated with the presence of advanced underlying heart disease and numerous cardiac and non-cardiac comorbidities with significant structural remodeling of the atrial myocardium. Due to limited efficacy and serious side effects of antiarrhythmic drugs, catheter ablation of atrial fibrillation, based on the pulmonary vein isolation for paroxysmal atrial fibrillation and adjunctive substrate modification for persistent atrial fibrillation, has emerged as an attractive and promissing alternative therapeutic option for selected patients with atrial fibrillation. In this review article, we discuss the electrophysiological left atrial abnormalities underlying lone atrial fibrillation and the role of pulmonary veins in pathophysiology of arrhythmia, and we summarize results of the studies on the long term outcome of catheter ablation of atrial fibrillation, as well as the studies on comparison of antiarrhythmic drugs with catheter ablation for treatment of atrial fibrillation. In addition, we present available data that provide better understanding of mechanisms, diagnosis, prevention and treatment of specific procedure-related complications and discuss current periprocedural anticoagulation strategies and their impact on the thromboembolic risk reduction.
Authors:
Milan M Marinković; Tatjana S Potpara; László Gellér; Nebojša M Mujović
Related Documents :
15374146 - Prognostic implications of autonomic nervous system analysis in chronic heart failure: ...
6395756 - Computer recognition of cardiac arrhythmias and statistical approaches to arrhythmia an...
7091376 - Functional significance of reduced cardiac sympathetic innervation in the newborn dog.
25412756 - Effects of insulin resistance on myocardial blood flow and arterial peripheral circulat...
16157956 - Efficacy of nifekalant hydrochloride in the treatment of fatal ventricular arrhythmia i...
154916 - Pulsus alternans induced by glyceryl trinitrate paste in a patient with alcoholic cardi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-25
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-9-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  PATHOPHYSIOLOGY OF IDIOPATHIC ATRIAL FIBRILLATION-PROGNOSTIC AND TREATMENT IMPLICATIONS.
Next Document:  Genetic Aspects of Lone Atrial Fibrillation: What Do We Know?